These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1081591)

  • 21. The effects of reserpine, L-dopa and 5-hydroxytryptophan on 5-hydroxyindoleacetic and homovanillic acids in cerebrospinal fluid, behaviour and EEG in cats.
    Buckingham RL; Radulovacki M
    Neuropharmacology; 1976 Jul; 15(7):389-92. PubMed ID: 1086441
    [No Abstract]   [Full Text] [Related]  

  • 22. [Depression and serotonin metabolism].
    Mitsunobu K
    Nihon Rinsho; 1978; 36(1):83-9. PubMed ID: 416250
    [No Abstract]   [Full Text] [Related]  

  • 23. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486.
    Van Woert MH; Sethy VH
    Neurology; 1975 Feb; 25(2):135-40. PubMed ID: 1078720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)].
    Carrieri P; Campanella G; Mandarini A; Orefice G; Buscaino GA
    Acta Neurol (Napoli); 1976; 31(5):558-64. PubMed ID: 1015382
    [No Abstract]   [Full Text] [Related]  

  • 25. Parkinson's disease. Modification by 5-hydroxytryptophan.
    Chase TN; Ng LK; Watanabe AM
    Neurology; 1972 May; 22(5):479-84. PubMed ID: 4563493
    [No Abstract]   [Full Text] [Related]  

  • 26. Altered serotonin metabolism in depressed patients with parkinson's disease.
    Mayeux R; Stern Y; Cote L; Williams JB
    Neurology; 1984 May; 34(5):642-6. PubMed ID: 6200801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers.
    Jönsson EG; Bah J; Melke J; Abou Jamra R; Schumacher J; Westberg L; Ivo R; Cichon S; Propping P; Nöthen MM; Eriksson E; Sedvall GC
    BMC Psychiatry; 2004 Mar; 4():4. PubMed ID: 15102340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of 5-hydroxyindole compounds during L-5-HTP treatment in depressed patients.
    Takahashi S; Takahashi R; Masumura I; Miike A
    Folia Psychiatr Neurol Jpn; 1976; 30(4):461-73. PubMed ID: 1087913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Central metabolism of dopamine and serotonin. III. Preliminary findings on the relations between dopamine metabolism and purine metabolism in the nervous system].
    Campanella G; Orefice G; Carrieri P; Mandarini A; Buscaino GA
    Acta Neurol (Napoli); 1976; 31(5):571-9. PubMed ID: 138341
    [No Abstract]   [Full Text] [Related]  

  • 30. Amitriptyline in man: decreased formation of central 5-hydroxyindoleacetic acid.
    Bowers MB
    Clin Pharmacol Ther; 1974 Feb; 15(2):167-70. PubMed ID: 4590800
    [No Abstract]   [Full Text] [Related]  

  • 31. [Central serotonin metabolism in depression].
    van Praag HM
    Ned Tijdschr Geneeskd; 1980 Jun; 124(24):964-71. PubMed ID: 6966766
    [No Abstract]   [Full Text] [Related]  

  • 32. Concentration of 5-hydroxyindoleacetic acid, homovanillic acid, and tryptophan in the cerebrospinal fluid of depressed patients before and after ECT.
    Abrams R; Essman WB; Taylor MA; Fink M
    Biol Psychiatry; 1976 Feb; 11(1):85-90. PubMed ID: 1260078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of tryptophan and a tryptophan/5-hydroxytryptophan combination on indoles in the brains of rats fed a tryptophan deficient diet.
    Clark JA; Clark MS; Palfreyman ES; Palfreyman MG
    Psychopharmacologia; 1975 Dec; 45(2):183-8. PubMed ID: 1082600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of peripheral decarboxylase inhibition on HVA and 5HIAA in cerebrospinal fluid of depressed patients.
    Gaillard JM; Constantinidis J; Tissot R
    Neuropsychobiology; 1975; 1(1):26-31. PubMed ID: 1223666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of L-tryptophan on brain serotonin metabolism in depressed patients.
    Dunner DL; Goodwin FK
    Arch Gen Psychiatry; 1972 Apr; 26(4):364-6. PubMed ID: 4552129
    [No Abstract]   [Full Text] [Related]  

  • 36. [Central metabolism of dopamine and serotonin. IV. Preliminary determinations of cerebrospinal fluid HVA and 5-HIAA in epileptic syndromes].
    Mandarini A; Buscaino GA; Rossi V; Orefice G; Carrieri P; Campanella G
    Acta Neurol (Napoli); 1976; 31(5):628-31. PubMed ID: 1015386
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of L-DOPA treatment on brain serotonin metabolism in depressed patients.
    Goodwin FK; Dunner DL; Gershon ES
    Life Sci I; 1971 Jul; 10(13):751-9. PubMed ID: 5142955
    [No Abstract]   [Full Text] [Related]  

  • 38. Toward a biochemical classification of depression.
    van Praag HM
    Adv Biochem Psychopharmacol; 1974; 11(0):357-68. PubMed ID: 4845704
    [No Abstract]   [Full Text] [Related]  

  • 39. CSF monoamine metabolites of depressed patients during illness and after recovery.
    Träskman-Bendz L; Asberg M; Bertilsson L; Thorén P
    Acta Psychiatr Scand; 1984 Apr; 69(4):333-42. PubMed ID: 6202099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-hydroxytryptophan in combination with clomipramine in "therapy-resistant" depressions.
    van Praag HM; van den Burg W; Bos ER; Dols LC
    Psychopharmacologia; 1974; 38(3):267-9. PubMed ID: 4547418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.